More articles from Review

  • Proton pump inhibitor side effects and drug interactions: Much ado about nothing?
    Proton pump inhibitor side effects and drug interactions: Much ado about nothing?
    Ryan D. Madanick, MD
    Cleveland Clinic Journal of Medicine January 2011, 78 (1) 39-49; DOI: https://doi.org/10.3949/ccjm.77a.10087

    In general, the safety of this class of drugs has been excellent. However, epidemiologic studies have indicated risks that are biologically plausible.

  • Premenopausal osteoporosis, an overlooked consequence of anorexia nervosa
    Kathryn Teng, MD
    Cleveland Clinic Journal of Medicine January 2011, 78 (1) 50-58; DOI: https://doi.org/10.3949/ccjm.78a.10023

    Particularly at risk are female athletes. The etiology is complex; the key treatment is to restore body weight.

  • Managing bloodstream infections in patients who have short-term central venous catheters
    Naomi P. O’grady, MD and Daniel S. Chertow, MD
    Cleveland Clinic Journal of Medicine January 2011, 78 (1) 10-17; DOI: https://doi.org/10.3949/ccjm.77a.10015

    Should a potentially infected catheter be removed? Which empiric antibiotic therapy should be started? And how should therapy be tailored to the specific pathogen?

  • The homocysteine hypothesis: Still relevant to the prevention and treatment of cardiovascular disease?
    Joellyn M. Abraham, MD and Leslie Cho, MD
    Cleveland Clinic Journal of Medicine December 2010, 77 (12) 911-918; DOI: https://doi.org/10.3949/ccjm.77a.10036

    Elevated homocysteine is a risk factor, and vitamins lower homocysteine levels. But does vitamin supplementation prevent cardiovascular events?

  • Managing gout: How is it different in patients with chronic kidney disease?
    Hossam El-Zawawy, MD, MS and Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2010, 77 (12) 919-928; DOI: https://doi.org/10.3949/ccjm.77a.09080

    The goals are the same, but the choice and dosage of drugs may need to be modified.

  • When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
    David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

    Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

  • Approach to a low TSH level: Patience is a virtue
    Approach to a low TSH level: Patience is a virtue
    Kevin M. Pantalone, DO and Christian Nasr, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 803-811; DOI: https://doi.org/10.3949/ccjm.77a.10056

    Confronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.

  • Should anticoagulation be resumed after intracerebral hemorrhage?
    Joshua N. Goldstein, MD, PhD and Steven M. Greenberg, MD, PhD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 791-799; DOI: https://doi.org/10.3949/ccjm.77a.10018

    In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.

  • Influenza 2010–2011: Lessons from the 2009 pandemic
    Michael G. Ison, MD, MS and Nelson Lee, MD
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 812-820; DOI: https://doi.org/10.3949/ccjm.77a.10135

    The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.

  • Management of hyponatremia: Providing treatment and avoiding harm
    Management of hyponatremia: Providing treatment and avoiding harm
    Chirag Vaidya, MD, Warren Ho, MD and Benjamin J. Freda, DO
    Cleveland Clinic Journal of Medicine October 2010, 77 (10) 715-726; DOI: https://doi.org/10.3949/ccjm.77a.08051

    Undercorrection of acute symptomatic hyponatremia can lead to serious neurologic injury, but so can overly rapid correction of chronic hyponatremia.

Pages